JP2016222694A - Production method of nano liposome for cosmetics in which oleanolic acid is collected - Google Patents

Production method of nano liposome for cosmetics in which oleanolic acid is collected Download PDF

Info

Publication number
JP2016222694A
JP2016222694A JP2016144525A JP2016144525A JP2016222694A JP 2016222694 A JP2016222694 A JP 2016222694A JP 2016144525 A JP2016144525 A JP 2016144525A JP 2016144525 A JP2016144525 A JP 2016144525A JP 2016222694 A JP2016222694 A JP 2016222694A
Authority
JP
Japan
Prior art keywords
oleanolic acid
cosmetics
lecithin
collected
nanoliposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016144525A
Other languages
Japanese (ja)
Other versions
JP6231624B2 (en
Inventor
ボン ソー ピ
Bong Soo Pi
ボン ソー ピ
スン イル パク
Sung Il Park
スン イル パク
ジョン チョル ハ
Jeong Cheol Ha
ジョン チョル ハ
ヨウン ジョン キム
Youn Joon Kim
ヨウン ジョン キム
サン フン ハン
Sang Hoon Han
サン フン ハン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of JP2016222694A publication Critical patent/JP2016222694A/en
Application granted granted Critical
Publication of JP6231624B2 publication Critical patent/JP6231624B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size

Abstract

PROBLEM TO BE SOLVED: To provide production methods of nano liposome for cosmetics in which oleanolic acid is collected as an active ingredient having excellent wrinkle improving effect.SOLUTION: The invention provides a production method of nano liposome for cosmetics in which oleanolic acid is collected, comprising the steps of: homogeneously mixing one or more polyol components selected from the group consisting of propylene glycol, glycerin, and these mixtures, an oil soluble component that is C10-40 fatty alcohol, and a phospholipid component that is lecithin, and obtaining a mixture; adding oleanolic acid into the mixture; cooling it, adding ethanol, and then homogeneously mixing; and adding a surfactant and water into the mixed solution and then homogeneously mixing it.SELECTED DRAWING: None

Description

本発明は、シワ改善の有効成分としてオレアノール酸が捕集された化粧料用ナノリポソームの製造方法に関する。   The present invention relates to a method for producing nanoliposomes for cosmetics in which oleanolic acid is collected as an active ingredient for improving wrinkles.

皮膚は、人体の一次防御膜であって、体内の諸器官を温度及び湿度変化や、紫外線、公害物質など外部環境の刺激から保護し、且つ、体温調節などの生体恒常性の維持にも重要な役割をしている。しかし、外部から受ける過度な物理的・化学的刺激及びストレス、栄養欠乏などは、皮膚の正常機能を低下させ、弾力損失、角質化、シワ生成などの皮膚老化現象を促進させることになる。このような現象を防止してより健康で且つ弾力のある皮膚を保つために、従来に使用された殆どの化粧料は、効能が微弱であったり皮膚の副作用を誘発するなど様々な問題点を有していた(韓国特許公開10−2010−0064451)。   The skin is the primary protective film of the human body, protecting various organs in the body from changes in temperature and humidity, ultraviolet rays, pollutants, and other external environmental stimuli, and also important for maintaining homeostasis such as body temperature regulation. Has a role to play. However, excessive physical and chemical stimuli, stress, and nutritional deficiencies received from the outside reduce the normal function of the skin and promote skin aging phenomena such as loss of elasticity, keratinization, and generation of wrinkles. In order to prevent such a phenomenon and maintain a healthier and more elastic skin, most of the cosmetics used in the past have various problems such as weak efficacy and inducing side effects on the skin. (Korean Patent Publication 10-2010-0064451).

皮膚の副作用を誘発しないながら、皮膚の老化防止効果を有する原料に対する研究が活発に進められている中、オレアノール酸を皮膚化粧料組成物に適用して優れた皮膚の老化防止効果を示すことを発見した。ヒドロキシ5環性テルペンの一種類であるオレアノール酸は、Eriobotrya japonica(loquata)、Perilla frutescens、Staphyleaholocarpaなどの多くの天然植物の有効成分であって、リンゴまたは梨のような果物内でも発見される。また、抗炎症、抗がん、抗アレルギー、抗憂鬱、そして抗菌、抗真菌などの薬理的な効果を有しており、特に皮膚の生理活性と関連して抗炎症及び刺激緩和などの効果を有している。また、抗老化機能としてコラーゲンの生成に重要なプロコラーゲンの合成を促進し、老化防止に重要なセラミド及びフィラグリーンの合成を促進し、生成されたコラーゲンなどの高分子タンパク質を破壊する酵素であるMMP−1の活性を阻害することで、コラーゲンの生成は促進し、コラーゲンの破壊は防ぐ二重老化防止システムを有することが特徴である。このように皮膚のシワ改善に優れた効果のあるオレアノール酸は、その間に多様な乳化化粧品剤形のシワ改善原料として使用されてきたが、水にほとんど溶けない難溶性であるだけでなく、化粧品に適用しても安定度及び力価不安定の問題によって、一定の含量以上含むのに限界があった。特に、このような難溶性の性質のため、化粧水のような可溶化剤形には、オレアノール酸をシワ改善原料として直接的に使用することは不可能な実情であった。   While research on raw materials having anti-aging effects on skin without inducing skin side effects, oleanolic acid is applied to skin cosmetic compositions to exhibit excellent anti-aging effects on skin. discovered. Oleanolic acid, a type of hydroxypentacyclic terpene, is an active ingredient in many natural plants such as Eriobotrya japonica (loquata), Perilla frutescens, Staphyleohalocarpa, and is also found in fruits such as apples or pears. In addition, it has pharmacological effects such as anti-inflammatory, anti-cancer, anti-allergy, anti-depressive, antibacterial and anti-fungal. Especially, it has anti-inflammatory and stimulating effects related to the physiological activity of the skin. Have. It is an enzyme that promotes the synthesis of procollagen, which is important for the production of collagen as an anti-aging function, promotes the synthesis of ceramide and filler green, which are important for the prevention of aging, and destroys macromolecular proteins such as collagen produced. It is characterized by having a double anti-aging system that inhibits the activity of MMP-1 to promote collagen production and prevent collagen destruction. In this way, oleanolic acid, which has an excellent effect on improving skin wrinkles, has been used as a wrinkle-improving raw material in various emulsified cosmetic dosage forms, but it is not only slightly soluble in water but also cosmetics. Even if it is applied to the above, there is a limit to including a certain content or more due to problems of stability and instability. In particular, due to such poorly soluble properties, it has been impossible to directly use oleanolic acid as a wrinkle-improving raw material in solubilizing agents such as skin lotions.

最近、皮膚の脂質類似組成のナノ技術を利用してオレアノール酸の成分を100〜150nm大きさのナノエマルジョンにカプセル化し、天然多糖類のイヌリンを用いた高分子乳化剤で2次カプセル化することにより、安定性を高めて化粧品の剤形に関係なく、オレアノール酸を使用できる状況が展開されたが、乳化製品においては、このようにカプセル化されたオレアノール酸を剤形内に投入するとき、製造工程によるカプセルの破壊を防ぐために、50℃以下の温度及び低いホモ混合速度下で投入しなければならないという煩わしさがあり、特に可溶化剤形では、安定度及び力価不安定性が依然として存在している実情である。また、単純にオレアノール酸を使用することよりも、さらに多くの費用がかかるだけでなく、オレアノール酸のカプセル化のためにオレアノール酸に加えて追加的な原料を使用することにより、製品の使用感に良くない影響を与えることができる。   Recently, by using nanotechnology of skin lipid-like composition, oleanolic acid components are encapsulated in nanoemulsions with a size of 100-150 nm, and then secondary encapsulated with a polymer emulsifier using natural polysaccharide inulin. The situation where oleanolic acid can be used regardless of the cosmetic dosage form has been developed to improve stability, but in emulsified products, when oleanolic acid thus encapsulated is put into the dosage form, In order to prevent capsule breakage due to the process, there is annoyance that it must be introduced at a temperature of 50 ° C. or lower and a low homomixing speed, and in particular, in the solubilizer form, stability and titer instability still exist. It is the actual situation. It is not only more expensive than simply using oleanolic acid, but also the product feel by using additional ingredients in addition to oleanolic acid for oleanolic acid encapsulation. Can have a negative effect.

また、全世界的に有機農認証化粧品の市場が大きくなっている時点において、オレアノール酸は、唯一に天然由来のシワ機能性成分として認められたが、前に言及した皮膚の脂質類似組成のナノ技術を利用してオレアノール酸をカプセル化した場合には、有機農認証化粧品に使用できない成分が多数含まれているので、有機農認証化粧品の原料として使用できなくなる。   In addition, at the time when the market for organic agricultural certified cosmetics has grown globally, oleanolic acid was only recognized as a naturally-occurring wrinkle functional ingredient. When oleanolic acid is encapsulated using technology, many ingredients that cannot be used in organic agricultural certified cosmetics are contained, and therefore cannot be used as raw materials for organic agricultural certified cosmetics.

本発明は、上記した従来技術の問題点を解決するために、シワ改善効果に優れたオレアノール酸を他の追加的な原料を使用してカプセル化することなく、単独でナノリポソームに安定するように捕集させる製造方法を提供することを目的とする。   In order to solve the above-mentioned problems of the prior art, the present invention is to stabilize oleanolic acid excellent in wrinkle improvement effect into nanoliposomes alone without encapsulating using other additional raw materials. It aims at providing the manufacturing method which makes it collect.

上記した目的を達成するために、本発明は、オレアノール酸が捕集された化粧料用ナノリポソームの製造方法を提供する。   In order to achieve the above object, the present invention provides a method for producing nanoliposomes for cosmetics in which oleanolic acid is collected.

本発明の製造方法で得られたナノリポソームを含む化粧料組成物は、皮膚のシワ改善に効果的なオレアノール酸をナノリポソーム内に捕集させて剤形内に安定化することにより、ナノリポソームによって経皮吸収の速度が増加され、コラーゲンの合成を促進することで優れたシワ改善効果を提供し、また、オレアノール酸を安定化させるための追加的な原料を投入せずに製品製造の単価を減らすことができる。また、爽やかで吸収後の水分感のある使用感を提供することができ、全世界的に増加している有機農のシワ機能性化粧品に対する消費者の需要を充足させることができる。   The cosmetic composition containing the nanoliposome obtained by the production method of the present invention is obtained by collecting oleanolic acid effective in improving skin wrinkle in the nanoliposome and stabilizing it in the dosage form. Increases the rate of percutaneous absorption, promotes the synthesis of collagen, provides an excellent wrinkle-improving effect, and does not require additional raw materials to stabilize oleanolic acid. Can be reduced. In addition, it is possible to provide a refreshing and moist feeling after absorption, thereby satisfying the consumer demand for organic agricultural wrinkle functional cosmetics that are increasing worldwide.

本発明は、有効成分としてオレアノール酸を含有するナノリポソームを提供し、前記ナノリポソームを含む化粧料組成物は、可溶化の形態で剤形化することができる。前記オレアノール酸は、ナノリポソーム内に捕集されており、ナノリポソームによって安定化させることにより、可溶化の剤形内でオレアノール酸の安定性及び溶解度を高めることができ、経皮吸収率を高めることができる。   The present invention provides nanoliposomes containing oleanolic acid as an active ingredient, and a cosmetic composition comprising the nanoliposomes can be formulated in a solubilized form. The oleanolic acid is collected in the nanoliposomes, and stabilized by the nanoliposomes can increase the stability and solubility of the oleanolic acid within the solubilized dosage form, increasing the transdermal absorption rate. be able to.

本発明で使用されるオレアノール酸は、天然由来のシワ機能性成分として唯一に認められたものであって、本発明では、組成物の総重量に対して0.0001〜5.0重量%、好ましくは0.0005〜1.0重量%の量で含有する。0.0001重量%未満の濃度では、明確な効果を期待することができず、5.0重量%超過の濃度では、含有量増加による明確な効果の増加が現れないだけでなく、剤形安定度に良くない影響を及ぼすからである。   The oleanolic acid used in the present invention is uniquely recognized as a naturally occurring wrinkle functional ingredient, and in the present invention, 0.0001 to 5.0% by weight based on the total weight of the composition, Preferably it is contained in an amount of 0.0005 to 1.0% by weight. If the concentration is less than 0.0001% by weight, a clear effect cannot be expected. If the concentration exceeds 5.0% by weight, not only a clear increase in the effect due to an increase in the content does not appear, but also the dosage form is stable. This is because it has a bad effect every time.

本発明の製造方法で得られるナノリポソームは、リポソームの形態を有するもので、平均粒子直径が10〜500nmのリポソームを意味し、本発明で形成されるナノリポソームの大きさは、好ましくは50〜300nmである。ナノリポソームの平均粒子直径が300nmを超過する場合には、本発明で達成しようとする技術的効果のうち皮膚浸透の改善及び剤形安定性の改善が非常に微弱なためである。   The nanoliposome obtained by the production method of the present invention has a liposome form, means a liposome having an average particle diameter of 10 to 500 nm, and the size of the nanoliposome formed by the present invention is preferably 50 to 300 nm. This is because, when the average particle diameter of the nanoliposome exceeds 300 nm, among the technical effects to be achieved by the present invention, improvement of skin penetration and improvement of dosage form stability are very weak.

本発明でオレアノール酸の安定化のために形成されるナノリポソームは、ポリオール、油性成分、界面活性剤、リン脂質、及び水を含む混合物によって製造される。また、可溶化化粧料組成物に含まれているオレアノール酸を捕集しているナノリポソームは、高圧乳化や別途の製造工程なしで単純に可溶化化粧料組成物を製造する時、自然に形成されることを特徴とする。   The nanoliposomes formed for the stabilization of oleanolic acid in the present invention are produced by a mixture comprising a polyol, an oily component, a surfactant, a phospholipid, and water. In addition, nanoliposomes that collect oleanolic acid contained in solubilized cosmetic compositions are formed spontaneously when producing solubilized cosmetic compositions simply without high-pressure emulsification or a separate manufacturing process. It is characterized by being.

本発明の製造方法で得られるナノリポソームを含む可溶化化粧料組成物に用いられるポリオールは、特に制限されず、好ましくは、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、グリセリン、メチルプロパンジオール、イソプロピレングリコール、ペンチレングリコール、エリトリトール、キシリトール、ソルビトール及びこれらの混合物で構成された群から選択される1種以上である。また、前記ポリオールは、ナノリポソームを含む可溶化化粧料組成物の総重量に対して5〜50重量%、好ましくは15〜30重量%の量で使用される。   The polyol used in the solubilized cosmetic composition containing nanoliposomes obtained by the production method of the present invention is not particularly limited, and is preferably propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, methylpropane. One or more selected from the group consisting of diol, isopropylene glycol, pentylene glycol, erythritol, xylitol, sorbitol, and mixtures thereof. The polyol is used in an amount of 5 to 50% by weight, preferably 15 to 30% by weight, based on the total weight of the solubilized cosmetic composition containing nanoliposomes.

本発明の製造方法で得られるナノリポソームを含む可溶化化粧料組成物に用いられる油性成分は、当業界に公知された多様なオイルが利用されることができ、好ましくは、ヘキサデカン及びパラフィンオイルのようなハイドロカーボン系オイル、エステル系の合成オイル、ジメチコン及びシクロメチコン系のようなシリコーンオイル、ひまわり油、トウモロコシ油、大豆油、アボカド油、ごま油、及び漁油のような動植物性オイル、エトキシ化アルキルエーテル系オイル、プロポキシル化アルキルエーテル系オイル、フィトスフィンゴシン(phytosphingosine)、スフィンゴシン及びスフィンガニンのようなスフィンゴ脂質、セレブロシドコレステロール、シトステロール硫酸コレステリル、硫酸シトステロール、C10-40脂肪アルコール、並びにこれらの混合物である。その使用量は、ナノリポソームを含む可溶化化粧料組成物の総重量に対して0.01〜10.0重量%であり、好ましくは1.0〜5.0重量%である。 As the oil component used in the solubilized cosmetic composition containing nanoliposomes obtained by the production method of the present invention, various oils known in the art can be used, preferably hexadecane and paraffin oil. Hydrocarbon oils, ester synthetic oils, silicone oils such as dimethicone and cyclomethicone, sunflower oil, corn oil, soybean oil, avocado oil, sesame oil, and animal and vegetable oils such as fishing oil, ethoxylation alkyl ether-based oil, propoxylated alkyl ether-based oil, sphingolipids such as phytosphingosine (phytosphingosine), sphingosine and sphinganine, cerebroside, cholesterol, sitosterol cholesteryl sulfate, sitosterol sulfate, C 10-40 fat Alcohol, and mixtures thereof. The usage-amount is 0.01 to 10.0 weight% with respect to the total weight of the solubilized cosmetic composition containing a nanoliposome, Preferably it is 1.0 to 5.0 weight%.

本発明の製造方法で得られるナノリポソームを含む可溶化化粧料組成物に用いられる界面活性剤は、当業界に公知されたいずれのものを使用してもよい。例えば、本発明で界面活性剤としては、アニオン性界面活性剤、カチオン性界面活性剤、両性界面活性剤、及び非イオン性界面活性剤を使用することができ、好ましくは、アニオン性界面活性剤及び非イオン性界面活性剤を使用することができる。アニオン性界面活性剤の具体的な例としては、アルキルアシルグルタミン酸塩、アルキルリン酸塩、アルキル乳酸、ジアルキルリン酸塩及びトリアルキルリン酸塩を含む。非イオン性界面活性剤の具体的な例は、ポリソルベート、アルコキシル化アルキルエーテル、アルコキシル化アルキルエステル、アルキルポリグリコシド、ポリグリセリルエステル、及び糖エステルを含む。前記界面活性剤の使用量は、ナノリポソームを含む可溶化化粧料組成物の総重量に対して0.001〜5.0重量%であり、好ましくは0.1〜1.0重量%である。   As the surfactant used in the solubilized cosmetic composition containing nanoliposomes obtained by the production method of the present invention, any surfactant known in the art may be used. For example, as the surfactant in the present invention, an anionic surfactant, a cationic surfactant, an amphoteric surfactant, and a nonionic surfactant can be used, and preferably an anionic surfactant And nonionic surfactants can be used. Specific examples of the anionic surfactant include alkyl acyl glutamate, alkyl phosphate, alkyl lactic acid, dialkyl phosphate and trialkyl phosphate. Specific examples of nonionic surfactants include polysorbates, alkoxylated alkyl ethers, alkoxylated alkyl esters, alkyl polyglycosides, polyglyceryl esters, and sugar esters. The amount of the surfactant used is 0.001 to 5.0% by weight, preferably 0.1 to 1.0% by weight, based on the total weight of the solubilized cosmetic composition containing nanoliposomes. .

本発明で形成されるナノリポソームにおいてリン脂質は、両親媒性脂質が利用され、天然リン脂質(例えば、卵黄レシチンまたは大豆レシチン、スフィンゴミエリン)及び合成リン脂質(例えば、ジパルミトイルホスファチジルコリン又は水素化レシチン)を含み、好ましくはレシチンである。特に、大豆または卵黄で抽出した天然由来の不飽和レシチンまたは飽和レシチンが好ましい。通常的に天然由来のレシチンは、ホスファチジルコリンの量が23〜95%、そしてホスファチジルエタノールアミンの量が20%以下である。本発明のナノリポソームを含む可溶化化粧料組成物の製造において、リン脂質の使用量は、可溶化化粧料組成物の総重量に対して0.01〜5.0重量%であり、好ましくは0.5〜2.0重量%である。   In the nanoliposomes formed in the present invention, an amphipathic lipid is used as the phospholipid, and a natural phospholipid (eg, egg yolk lecithin or soybean lecithin, sphingomyelin) and a synthetic phospholipid (eg, dipalmitoyl phosphatidylcholine or hydrogenated lecithin) ), Preferably lecithin. In particular, naturally derived unsaturated lecithin or saturated lecithin extracted with soybean or egg yolk is preferable. Usually naturally derived lecithin has a phosphatidylcholine content of 23-95% and a phosphatidylethanolamine content of 20% or less. In the production of the solubilized cosmetic composition containing the nanoliposome of the present invention, the amount of phospholipid used is 0.01 to 5.0% by weight with respect to the total weight of the solubilized cosmetic composition, preferably 0.5 to 2.0% by weight.

本発明の製造方法で得られるナノリポソームを含む可溶化化粧料組成物で用いられる水は、一般的に脱イオン化された蒸留水であり、水の使用量は、可溶化化粧料組成物の総重量に対して25.0〜90.0重量%である。   The water used in the solubilized cosmetic composition containing nanoliposomes obtained by the production method of the present invention is generally deionized distilled water, and the amount of water used is the total amount of the solubilized cosmetic composition. It is 25.0-90.0 weight% with respect to a weight.

本発明の製造方法で得られるナノリポソームを含む可溶化化粧料組成物は、オレアノール酸を含有することにより、特に優れたシワ改善効果を提供する抗老化用の組成物として使用される。   The solubilized cosmetic composition containing the nanoliposome obtained by the production method of the present invention is used as an anti-aging composition which provides a particularly excellent wrinkle-improving effect by containing oleanolic acid.

また、本発明の製造方法で得られるナノリポソームを含む組成物は、その剤形において特別な制限はないが、透明または懸濁液状の外観および使用上の長所を考慮すれば、柔軟化粧水、栄養化粧水、スプレー、ミストまたはゲル等の基礎化粧料;ヘアトニック、ヘアエッセンス又はヘアトリートメントなどの養毛剤のような毛髪用化粧料組成物;その他の医薬品及び医薬部外品などに幅広く適用することができ、人の皮膚に塗布された時にも副作用なしで安全で且つ効果が優れた皮膚のシワ改善剤として使用することができる。   In addition, the composition containing the nanoliposome obtained by the production method of the present invention is not particularly limited in its dosage form, but considering the transparent or suspension appearance and the advantages in use, Basic cosmetics such as nourishing lotions, sprays, mists or gels; hair cosmetic compositions such as hair tonics, hair essences or hair treatments; other pharmaceuticals and quasi-drugs It can be used as a skin wrinkle-improving agent that is safe and effective without side effects even when applied to human skin.

本発明の製造方法で得られるナノリポソームを含む組成物は、脂肪物質、有機溶媒、溶解剤、濃縮剤及びゲル化剤、軟化剤、抗酸化剤、懸濁化剤、安定化剤、発泡剤、芳香剤、界面活性剤、水、イオン型若しくは非イオン型乳化剤、充填剤、金属イオン封鎖剤及びキレート化剤、保存剤、ビタミン、遮断剤、湿潤化剤、必須オイル、染料、顔料、親水性若しくは親油性の活性剤、脂質小胞、又は化粧品に通常的に用いられる任意の他成分のような化粧品学若しくは皮膚科学分野で通常的に用いられる補助剤を含有することができる。これらの補助剤は、化粧品学または皮膚科学分野で一般的に使用される量で導入される。   The composition containing nanoliposomes obtained by the production method of the present invention comprises a fatty substance, an organic solvent, a solubilizer, a thickener and a gelling agent, a softening agent, an antioxidant, a suspending agent, a stabilizing agent, and a foaming agent. , Fragrances, surfactants, water, ionic or non-ionic emulsifiers, fillers, sequestering and chelating agents, preservatives, vitamins, blocking agents, wetting agents, essential oils, dyes, pigments, hydrophilic Adjuncts commonly used in the cosmetics or dermatological field such as active or lipophilic active agents, lipid vesicles, or any other ingredient normally used in cosmetics. These adjuvants are introduced in amounts commonly used in the cosmetics or dermatological fields.

以下、実施例及び試験例を通じて本発明をさらに具体的に説明する。しかし、以下の実施例、実験例及び製造例は、本発明に対する理解を助けるために例示の目的のみで提供されるものに過ぎず、本発明の範疇及び範囲がこれに限定されないことを明らかにする。   Hereinafter, the present invention will be described more specifically through examples and test examples. However, the following examples, experimental examples, and preparation examples are provided for illustrative purposes only to assist in understanding the present invention, and it is clear that the scope and scope of the present invention is not limited thereto. To do.

[参考例1]ナノリポソームで安定化されたオレアノール酸の可溶化化粧水の製造
下記の表1に記載された組成によって実施例1〜3及び比較例1〜4のシワ改善用の可溶化化粧水を製造した(単位:重量%)。
実施例1〜3は、本発明に係るナノリポソームを形成するとともに、前記ナノリポソームが含まれる可溶化化粧水であり、比較例1〜2は、実施例1〜3とは異なる一般的な可溶化剤を使用したものであり、比較例3は、オレアノール酸をカプセル化されたオレアノール酸ナノベースの形態で含むものである。比較例4は、オレアノール酸をエタノールとプロピレングリコール4:1の比率の混合物に溶解させたものである。
[Reference Example 1] Preparation of oleanolic acid-stabilized skin lotion stabilized with nanoliposomes Solubilized makeup for improving wrinkles of Examples 1 to 3 and Comparative Examples 1 to 4 according to the composition described in Table 1 below Water was produced (unit: wt%).
Examples 1 to 3 are solubilized lotions that form the nanoliposomes according to the present invention and that contain the nanoliposomes. Comparative Examples 1 and 2 are generally acceptable different from Examples 1 to 3. A solubilizer is used, and Comparative Example 3 contains oleanolic acid in an encapsulated oleanolic acid nano-based form. In Comparative Example 4, oleanolic acid was dissolved in a mixture of ethanol and propylene glycol 4: 1.

Figure 2016222694
Figure 2016222694

製造方法は、次の通りである。
1)成分1〜3とポリオールの成分4〜5を一度に投入し、80℃で加温溶解した後、成分6〜9を投入して均一に混合した。
2)1)の混合物を65℃で冷却した後、エタノール(成分10)を投入して十分に混合した。
3)成分11〜14の水相成分をあらかじめ均一に混合した後、65℃で加熱した後、2)の混合物と均一に混合した。
4)前記3)を室温で冷却して保管した。
The manufacturing method is as follows.
1) Components 1 to 3 and polyol components 4 to 5 were added at a time, heated and dissolved at 80 ° C., and then components 6 to 9 were added and mixed uniformly.
2) After the mixture of 1) was cooled at 65 ° C., ethanol (component 10) was added and mixed well.
3) The water phase components of components 11 to 14 were uniformly mixed in advance, then heated at 65 ° C., and then uniformly mixed with the mixture of 2).
4) The above 3) was cooled and stored at room temperature.

一方、比較例3の場合には、前記ステップ3)の次に、カプセル化されたオレアノール酸ナノベース(成分15)を投入する。   On the other hand, in the case of Comparative Example 3, after step 3), encapsulated oleanolic acid nanobase (component 15) is charged.

[試験例1]組成物の安定度評価
前記経時変化によるシワ改善用の可溶化化粧料組成物の安定度を調べるために、実施例1〜3及び比較例1〜4で製造した可溶化化粧水を室温、45℃の恒温槽及び−10℃から45℃に12時間の間隔で循環する恒温槽でそれぞれ1ヶ月間保管した後、外観の変化を観察した。
[Test Example 1] Composition Stability Evaluation Solubilized makeup produced in Examples 1 to 3 and Comparative Examples 1 to 4 in order to examine the stability of the solubilized cosmetic composition for improving wrinkles due to changes over time. The water was stored for 1 month in a thermostat bath at room temperature, 45 ° C. and a thermostat bath circulated from −10 ° C. to 45 ° C. at intervals of 12 hours, and the change in appearance was observed.

Figure 2016222694
Figure 2016222694

前記表2における結果を見れば、オレアノール酸をナノリポソームに捕集した実施例1〜3は、他の一般的な可溶化剤を使用した比較例1〜2よりも長期的に安定することが分かる。また、実施例2と比較例1〜2とを比較してみれば、オレアノール酸をナノリポソームに捕集して安定化させた実施例2で使用した界面活性剤の量が、比較に1〜2で使用した界面活性剤の量よりも、遥かに少ないことが分かる。これにより、ナノリポソームを形成してオレアノール酸を捕集する場合、剤形内に使用しなければならない界面活性剤の量をかなり減らせることが分かり、多量の界面活性剤を使用する場合の皮膚刺激に対する危険も避けることができる。   If the result in the said Table 2 is seen, Examples 1-3 which collected oleanolic acid in the nano liposome may be stabilized in the long term rather than Comparative Examples 1-2 which used another general solubilizer. I understand. In addition, comparing Example 2 with Comparative Examples 1-2, the amount of surfactant used in Example 2 in which oleanolic acid was collected and stabilized in nanoliposomes was compared with 1- It can be seen that it is much less than the amount of surfactant used in 2. This indicates that when nanoliposomes are formed to collect oleanolic acid, the amount of surfactant that must be used in the dosage form can be significantly reduced, and the skin when using large amounts of surfactant. Risk of irritation can also be avoided.

[試験例2]ナノリポソームを形成してオレアノール酸を安定化させた組成物と、カプセル化されたオレアノール酸を使用した組成物との使用感比較
前記実施例2及び比較例3の使用感を評価するために、実施例2及び比較例3で製造されたシワ改善用の可溶化化粧料組成物に対して官能試験を実施した。25〜35歳の女性20名を対象にして、それぞれのシワ改善用の可溶化化粧料組成物を一般的な使用法によって手の甲皮膚に塗布した後、使用感に対する満足度を評価するようにした。官能評価は、べたつき感、吸収感、保湿感、栄養感の総4項目であり、各項目に対して非常に優秀(10点)、優秀(7.5点)、普通(5点)、悪い(2.5点)、及び非常に悪い(0点)の基準に基づいて行い、この値を平均して下の表3に示した。
[Test Example 2] Comparison of feeling of use between a composition in which nanoliposomes are formed to stabilize oleanolic acid and a composition using encapsulated oleanolic acid In order to evaluate, a sensory test was carried out on the solubilized cosmetic composition for improving wrinkles produced in Example 2 and Comparative Example 3. For 20 women aged 25 to 35 years old, each wrinkle-improving solubilized cosmetic composition was applied to the back of the hand by a general usage method, and the satisfaction with the feeling of use was evaluated. . The sensory evaluation is a total of four items: stickiness, absorption, moisturizing, and nutrition. Very good (10 points), excellent (7.5 points), normal (5 points), and bad for each item. Based on the criteria of (2.5 points) and very bad (0 points), this value was averaged and shown in Table 3 below.

Figure 2016222694
Figure 2016222694

ナノリポソームを剤形内に形成してオレアノール酸を安定化させた実施例2と、カプセル化されたオレアノール酸を使用した比較例3とを比較してみる場合、同じ量のオレアノール酸を使用してもカプセル化されたオレアノール酸を使用した比較例3は、カプセル化されたオレアノール酸ナノベースを製造するために安定化物質を実施例2よりも約2.4重量%以上さらに使用するので、使用感に良くない影響を及ぼすということが分かり、使用感を比較した場合には、表3のように剤形内にナノリポソームを形成してオレアノール酸を安定化させた剤形の使用感が遥かに良いことが分かる。   When comparing Example 2 where nanoliposomes were formed in a dosage form to stabilize oleanolic acid and Comparative Example 3 using encapsulated oleanolic acid, the same amount of oleanolic acid was used. However, Comparative Example 3 using encapsulated oleanolic acid uses about 2.4% or more more of the stabilizing material than Example 2 to produce encapsulated oleanolic acid nanobases. When it was found that it had an unfavorable effect on the feeling and the feeling of use was compared, the feeling of use of the dosage form in which nanoliposomes were formed in the dosage form to stabilize oleanolic acid as shown in Table 3 was far You can see that it is good.

[試験例3]コラーゲン生合成促進効果の測定
前記実施例2のコラーゲン生合成促進効果に対して、コラーゲン生合成を促進すると知られているトコフェロール及びEGCGと比較して測定した。まず、ヒト線維芽細胞(fibroblast)(PromoCell,Germany)を24孔(well)に1孔当たり105個ずつ種まき(seeding)をして90%程度育つまで培養した。これを24時間の間に無血清DMEM培地で培養した
後、無血清培地に溶かした実施例2、トコフェロール及びEGCGをそれぞれ10-4モル濃度で処理し
、24時間の間にCO2培養器で培養した。これらの上層液を取ってプロコラーゲン型(I)エライザ(ELISA)キット(procollagen type(I))を利用してプロコラーゲン(procollagen)の増減の有無を観察した。その結果は、下記の表4に示した。ここで、合成能は、非処理群を100にして対比したものである。
[Test Example 3] Measurement of collagen biosynthesis promoting effect The collagen biosynthesis promoting effect of Example 2 was measured in comparison with tocopherol and EGCG which are known to promote collagen biosynthesis. First, human fibroblasts (PromoCell, Germany) were seeded in 24 wells at a rate of 10 5 per well and cultured until they grew to about 90%. This was cultured in serum-free DMEM medium for 24 hours, then treated with Example 4 tocopherol and EGCG dissolved in serum-free medium at 10 -4 molar concentrations, respectively, and in a CO 2 incubator for 24 hours. Cultured. These upper layer solutions were taken, and the presence or absence of increase or decrease of procollagen was observed using a procollagen type (I) ELISA (ELISA) kit (procollagen type (I)). The results are shown in Table 4 below. Here, the synthetic ability is compared with the untreated group as 100.

Figure 2016222694
Figure 2016222694

前記表4から分かるように、実施例2の組成物は、コラーゲン生合成を促進し、これは、コラーゲン生合成を促進すると知られているトコフェロール及びEGCGと比較しても、遥かに優れた効果を提供することが分かる。   As can be seen from Table 4 above, the composition of Example 2 promotes collagen biosynthesis, which is far superior to tocopherol and EGCG, which are known to promote collagen biosynthesis. You can see that

[試験例4]皮膚吸収量の測定
皮膚吸収は、モルモットの皮膚を対象にしてフランツ透過セルを利用して測定した。試験の直前、モルモットの腹部の部分の皮膚を採取して平方1cm2の面積で切断した後、これを透過鏡の直径が0.9cmの透過セルに設置してクランプで固定した。皮膚の一方の面〔ドナー(donor)容器〕は、オレアノール酸をエタノールとプロピレングリコール(4:1)に溶解させた比較例4のサンプルと、ナノリポソームで形成してオレアノール酸を安定化させた実施例2のサンプルとを、それぞれ0.2gずつ塗布し、他方の面〔受容(receptor)容器〕は、精製水とエタノールが4:1の重量比で混合された溶媒と接触するようにし、試験時の温度は、実際の皮膚温度である32℃を維持した。試験の開始後、一定の時間間隔で溶媒の一部を採取した後、HPLCを利用して皮膚に吸収されたオレアノール酸の量を測定し、経過時間による塗布濃度当たりの皮膚吸収量(μg/cm2/重量%)に示した。その結果を下記の表5に示した。
[Test Example 4] Measurement of skin absorption The skin absorption was measured using a Franz permeation cell for guinea pig skin. Immediately before the test, the skin of the abdomen of the guinea pig was collected and cut in an area of 1 cm 2 square, and then placed in a transmission cell having a transmission mirror diameter of 0.9 cm and fixed with a clamp. One side of the skin (donor container) was formed with nanoliposomes and samples of Comparative Example 4 in which oleanolic acid was dissolved in ethanol and propylene glycol (4: 1) to stabilize oleanolic acid. The sample of Example 2 was applied in an amount of 0.2 g each, and the other surface (receptor container) was brought into contact with a solvent in which purified water and ethanol were mixed at a weight ratio of 4: 1. The temperature during the test was maintained at 32 ° C., which is the actual skin temperature. After the start of the test, a part of the solvent was collected at regular time intervals, and then the amount of oleanolic acid absorbed into the skin was measured using HPLC, and the amount of skin absorbed per application concentration over time (μg / cm 2 / weight%). The results are shown in Table 5 below.

<HPLC分析条件>
−カラム:Waters Novapak C18(3.9mm×250mm、4um)
−溶媒流速:1ml/分
−検出UV:210nm
−サンプル測定濃度:10〜100ug/mL
−サンプル注入量:20uL
−溶離液:MeOH/0.1% H3PO4=82/18
<HPLC analysis conditions>
-Column: Waters Novapak C18 (3.9 mm x 250 mm, 4 um)
-Solvent flow rate: 1 ml / min -Detection UV: 210 nm
Sample measurement concentration: 10 to 100 ug / mL
-Sample injection volume: 20 uL
-Eluent: MeOH / 0.1% H 3 PO 4 = 82/18

Figure 2016222694
Figure 2016222694

前記表5の結果からナノリポソームの形成により、オレアノール酸を安定化させた実施例2の経皮吸収量が遥かに優秀であることが分かる。   From the results of Table 5, it can be seen that the transdermal absorption amount of Example 2 in which oleanolic acid is stabilized by the formation of nanoliposomes is far superior.

Claims (6)

1)プロピレングリコール、グリセリン及びこれらの混合物で構成された群から選択される1種以上のポリオール成分と、C10-40脂肪アルコールである油溶性成分と、レシチンであるリン脂質成分とを均一に混合して混合物を得るステップと、
2)ステップ1)の混合物にオレアノール酸を添加するステップと、
3)ステップ2)の混合物を冷却させ、エタノールを添加した後、均一に混合するステップと、
4)ステップ3)の混合液に界面活性剤と水を添加した後、これを均一に混合するステップを含むことを特徴とするオレアノール酸が捕集された化粧料用ナノリポソームの製造方法。
1) Uniformly comprising at least one polyol component selected from the group consisting of propylene glycol, glycerin and mixtures thereof, an oil-soluble component which is C 10-40 fatty alcohol, and a phospholipid component which is lecithin Mixing to obtain a mixture;
2) adding oleanolic acid to the mixture of step 1);
3) cooling the mixture of step 2), adding ethanol and then mixing uniformly;
4) A method for producing nanoliposomes for cosmetics in which oleanolic acid is collected, which comprises the step of adding a surfactant and water to the mixed solution of step 3) and then uniformly mixing them.
前記レシチンは、水素化レシチンであることを特徴とする請求項1に記載の製造方法。   The method according to claim 1, wherein the lecithin is hydrogenated lecithin. 前記レシチンの含量は、組成物総重量に対して、0.05〜1.0重量%であることを特徴とする請求項1又は2に記載の製造方法。   The production method according to claim 1 or 2, wherein the lecithin content is 0.05 to 1.0% by weight based on the total weight of the composition. 前記ナノリポソームは、平均粒子直径が50〜300nmであることを特徴とする請求項1〜3のいずれかに記載の製造方法。   The said nanoliposome has an average particle diameter of 50-300 nm, The manufacturing method in any one of Claims 1-3 characterized by the above-mentioned. 前記オレアノール酸に対する前記レシチンの使用比率は、重量を基準として、1:4であることを特徴とする請求項1〜4のいずれかに記載の製造方法。   The manufacturing method according to any one of claims 1 to 4, wherein the use ratio of the lecithin to the oleanolic acid is 1: 4 based on weight. 前記化粧料は、可溶化剤形を有する化粧料であることを特徴とする請求項1〜5のいずれかに記載の製造方法。   The said cosmetics are cosmetics which have a solubilizer form, The manufacturing method in any one of Claims 1-5 characterized by the above-mentioned.
JP2016144525A 2010-11-22 2016-07-22 Method for producing nanoliposomes for cosmetics in which oleanolic acid is collected Active JP6231624B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100116288A KR101821207B1 (en) 2010-11-22 2010-11-22 Solubilization cosmetic composition containing oleanolic acid
KR10-2010-0116288 2010-11-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013539759A Division JP6321962B2 (en) 2010-11-22 2011-11-17 Cosmetic composition containing oleanolic acid

Publications (2)

Publication Number Publication Date
JP2016222694A true JP2016222694A (en) 2016-12-28
JP6231624B2 JP6231624B2 (en) 2017-11-15

Family

ID=46146254

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013539759A Active JP6321962B2 (en) 2010-11-22 2011-11-17 Cosmetic composition containing oleanolic acid
JP2016144525A Active JP6231624B2 (en) 2010-11-22 2016-07-22 Method for producing nanoliposomes for cosmetics in which oleanolic acid is collected

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013539759A Active JP6321962B2 (en) 2010-11-22 2011-11-17 Cosmetic composition containing oleanolic acid

Country Status (6)

Country Link
JP (2) JP6321962B2 (en)
KR (1) KR101821207B1 (en)
CN (1) CN103221028B (en)
HK (1) HK1186963A1 (en)
SG (1) SG190131A1 (en)
WO (1) WO2012070804A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132070A1 (en) * 2017-12-27 2019-07-04 정한수 Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103830118A (en) * 2014-03-26 2014-06-04 清华大学 Application and use method of salidroside in preparing skin-care product for preventing skin photoaging
CN103830116B (en) * 2014-03-26 2017-01-04 清华大学 Ligustilide prevents purposes and the using method of skin photoage skin care item in preparation
JP6605794B2 (en) * 2014-09-22 2019-11-13 株式会社ファンケル Arginase 1 production promoter
WO2016140473A1 (en) * 2015-03-02 2016-09-09 (주)아모레퍼시픽 Multilamella nanoliposome which contains skin lipid components, and preparation method therefor
CN106309313A (en) * 2016-08-24 2017-01-11 彭友莲 Whitening facial cleanser and preparing method thereof
CN108403751B (en) * 2018-05-23 2021-04-06 阜阳师范学院 Application of triterpenoid saponin in trichosanthes peel
CN113413325B (en) * 2021-05-31 2022-04-05 宝萃生物科技有限公司 Lip plumping composition and preparation method and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004131502A (en) * 2002-10-09 2004-04-30 Pacific Corp Submicron-liposome containing triterpenoid at high concentration and method for preparing the same
CN1923178A (en) * 2006-08-22 2007-03-07 河南大学 Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation
WO2007078060A1 (en) * 2005-12-30 2007-07-12 Amorepacific Corporation Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same
KR20080038812A (en) * 2006-10-31 2008-05-07 (주)아모레퍼시픽 A cosmetic of sheet-type containing unsoluble material stably in a low viscosity level state
US20100055163A1 (en) * 2006-05-18 2010-03-04 Universidad De Granada Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100654846B1 (en) * 2004-12-02 2006-12-06 한국콜마 주식회사 Cosmetic composition comprising nano size liposome and oil in water type emulsion and manufacturing method thereof
KR20060087817A (en) * 2005-01-31 2006-08-03 주식회사 태평양 Anti-aging cosmetic composition
KR100654841B1 (en) * 2005-06-27 2006-12-06 한국콜마 주식회사 Lipid solution composition and method for preparing nano particle cosmetics having analogous structure and composition of human skin and promoting the transepidermal absorption of physiologically active substances using the same
JP2007224012A (en) * 2006-01-30 2007-09-06 Fujifilm Corp Enzymatically crosslinked protein nanoparticle
KR100792629B1 (en) * 2006-11-20 2008-01-09 (주)아모레퍼시픽 Skin whitening cosmetic composition containing oldenlandia diffusa extract stabilized with nano-liposome
JP2008297241A (en) * 2007-05-31 2008-12-11 Fujifilm Corp Anti-acne skin agent for external use
CN101843623B (en) * 2010-04-09 2012-03-14 澳门理工学院 External fat-increasing preparation and application thereof
CN101923178B (en) 2010-08-16 2012-05-23 中国海洋石油总公司 Sub-pixel matching-based towline dynamic acquisition influence eliminating method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004131502A (en) * 2002-10-09 2004-04-30 Pacific Corp Submicron-liposome containing triterpenoid at high concentration and method for preparing the same
WO2007078060A1 (en) * 2005-12-30 2007-07-12 Amorepacific Corporation Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same
US20100055163A1 (en) * 2006-05-18 2010-03-04 Universidad De Granada Formulation of natural triterpenes and biophenols obtained from the genus olea in liposomes
CN1923178A (en) * 2006-08-22 2007-03-07 河南大学 Oleanolic acid liposome preparation, freeze dried powder injecta thereof and its preparation
KR20080038812A (en) * 2006-10-31 2008-05-07 (주)아모레퍼시픽 A cosmetic of sheet-type containing unsoluble material stably in a low viscosity level state

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ISABELLE BONNET: "第2世代リポソーム技術により安定化された純ウルソル酸の開発と評価", FRAGRANCE JOURNAL, JPN6017036213, September 2006 (2006-09-01), pages 74 - 78, ISSN: 0003647865 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132070A1 (en) * 2017-12-27 2019-07-04 정한수 Antiaging cosmetic containing nanoparticle soluble product obtained by solubilizing poorly soluble oleanolic acid, and method for preparing antiaging cosmetics

Also Published As

Publication number Publication date
WO2012070804A3 (en) 2012-07-19
SG190131A1 (en) 2013-06-28
WO2012070804A2 (en) 2012-05-31
KR101821207B1 (en) 2018-01-24
JP2013542984A (en) 2013-11-28
HK1186963A1 (en) 2014-03-28
CN103221028A (en) 2013-07-24
CN103221028B (en) 2016-04-20
JP6321962B2 (en) 2018-05-09
JP6231624B2 (en) 2017-11-15
KR20120054906A (en) 2012-05-31

Similar Documents

Publication Publication Date Title
JP6231624B2 (en) Method for producing nanoliposomes for cosmetics in which oleanolic acid is collected
KR101934208B1 (en) Compositions for Moisturizing Skin Containing Vegetable Vernix Ingredients
JP6377381B2 (en) Liposome composition
KR20070081192A (en) Cosmetic compostion comprising liposome incorporating oryzanol, rice bran oil and phospholipid
KR20080106618A (en) Multi-emulsified vesicles comprising a multi lamellar liposome and phospholipid monolayer nanoliposomes
KR100501399B1 (en) Cosmetic Compostion for Preventing Skin Aging Comprising Plant Extract as Oriental Medicine Stabilized in Nanoliposome
KR20130023912A (en) Peptides stabilized using liposome and cosmeceutical composition thereof
KR101577874B1 (en) Liquid crystal cosmetic composition having similar skin lipid composition and containing glucosylceramide, and preparation method thereof
KR101176523B1 (en) A Cosmetic Composition having phase transformation
JP2005179313A (en) Method for producing base agent for skin cosmetic, and skin cosmetic
KR101176530B1 (en) Cosmetic Compositions for Sliming
KR101142010B1 (en) Cosmetic composition Comprising Moisture Quality Component As Active Ingredient
KR101325553B1 (en) Cosmetic Composition for Protecting Skin Comprising Aminolevulinic acid Contained in Liquid Crystal Base
KR100570093B1 (en) Cosmetic Compostion for Alleviating Skin Irritation Comprising Mung Bean Extract Stabilized in Nanoliposome
KR100858628B1 (en) Cosmetic Composition for alleviating Skin Irritation Comprising Rumex Crispus L. Extract Stabilized in Nanoliposome
KR100482355B1 (en) Liposome or nanoemulsion containing dipalmitoyl hydroxyproline and soy isoflavone and a cosmetic composition containing the liposome and/or the nanoemulsion and method thereof
KR101549624B1 (en) Temperature Sensitive Cosmetic Composition
KR101716426B1 (en) Skin external composition for alleviating itch comprising vernixcaseosamimetic lipid complex and arctium lappa seed extracts
KR20230021435A (en) Oil-in-water cosmetic composition comprising nanovesicles in which poorly soluble ingredients are stabilized
KR20170045430A (en) Liposome composition containg vinegar, preparation method thereof, and cosmetic composition comprising the same
JP4592347B2 (en) External preparation composition
KR20150078137A (en) Cosmetic composition for improving skin wrinkle
JP2002179549A (en) Skin care preparation
JP5329489B2 (en) External preparation composition
KR20230101213A (en) Composition With Improved Stability And Transdermal Delivery Rate Of Red Ginseng Oil And Preparing Method Thereof

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170926

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171019

R150 Certificate of patent or registration of utility model

Ref document number: 6231624

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250